QIAstat-Dx® Respiratory Panel Plus— 510(k) K233100

Substantially Equivalent

QIAGEN GmbH

FDA 510(k) clearance K233100 for QIAstat-Dx® Respiratory Panel Plus, Substantially Equivalent on 2024-05-10. Applicant: QIAGEN GmbH.

Clearance details

Applicant
QIAGEN GmbH
Product code
Code QOF
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Hilden, DE
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.